Great Lakes Advisors, LLC Viatris Inc Transaction History

Great Lakes Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$9.95 - $12.27 $128,295 - $158,209	-12,894 Reduced 41.99%	17,810 $186,000
Q1 2022 May 06, 2022	BUY	$9.81 - $15.4 $301,206 - $472,841	30,704 New	30,704 $334,000
Q4 2021 Feb 09, 2022	SELL	$12.09 - $14.68 $3.58 Million - $4.35 Million	-296,485 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$13.25 - $15.13 $1.59 Million - $1.82 Million	-120,290 Reduced 28.86%	296,485 $4.02 Million
Q2 2021 Aug 11, 2021	BUY	$12.97 - $16.15 $3.55 Million - $4.42 Million	273,455 Added 190.8%	416,775 $5.96 Million
Q1 2021 May 03, 2021	BUY	$13.59 - $18.54 $1.18 Million - $1.62 Million	87,112 Added 154.98%	143,320 $2 Million
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $803,774 - $1.05 Million	56,208 New	56,208 $1.05 Million

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.